Biodesix Inc. (BDSX): Price and Financial Metrics
BDSX Price/Volume Stats
| Current price | $0.28 | 52-week high | $2.04 |
| Prev. close | $0.30 | 52-week low | $0.17 |
| Day low | $0.27 | Volume | 1,899,500 |
| Day high | $0.30 | Avg. volume | 5,169,379 |
| 50-day MA | $0.46 | Dividend yield | N/A |
| 200-day MA | $1.13 | Market Cap | 41.30M |
BDSX Stock Price Chart Interactive Chart >
Biodesix Inc. (BDSX) Company Bio
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. It offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer; and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It is a data-driven diagnostic solutions company with proprietary AI platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The firm offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. . The company was founded in 2005 and is headquartered in Boulder, CO.
BDSX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BDSX Price Returns
| 1-mo | -33.92% |
| 3-mo | -67.52% |
| 6-mo | -79.26% |
| 1-year | -78.46% |
| 3-year | -84.36% |
| 5-year | N/A |
| YTD | -81.70% |
| 2024 | -16.85% |
| 2023 | -20.00% |
| 2022 | -56.52% |
| 2021 | -73.76% |
| 2020 | N/A |